KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Edwards Lifesciences (EW) Other Gross PP&E Adjustments (2019 - 2025)

Edwards Lifesciences has reported Other Gross PP&E Adjustments over the past 13 years, most recently at $841.6 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $841.6 million for Q4 2025, up 17.69% from a year ago — trailing twelve months through Dec 2025 was $841.6 million (up 17.69% YoY), and the annual figure for FY2025 was $841.6 million, up 17.69%.
  • Other Gross PP&E Adjustments for Q4 2025 was $841.6 million at Edwards Lifesciences, up from -$96.5 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for EW hit a ceiling of $841.6 million in Q4 2025 and a floor of -$104.4 million in Q3 2024.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$89.3 million (2021), compared with a mean of $5.3 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: fell 17.22% in 2021 and later skyrocketed 580.4% in 2024.
  • Edwards Lifesciences' Other Gross PP&E Adjustments stood at -$92.1 million in 2021, then decreased by 0.22% to -$92.3 million in 2022, then surged by 213.87% to $105.1 million in 2023, then skyrocketed by 580.4% to $715.1 million in 2024, then increased by 17.69% to $841.6 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $841.6 million (Q4 2025), -$96.5 million (Q3 2025), and -$99.0 million (Q2 2025) per Business Quant data.